MedPath
HSA Approval

COMIRNATY, DISPERSION FOR INJECTION IN PRE-FILLED SYRINGE, 30 MICROGRAMS/DOSE

SIN17235P

COMIRNATY, DISPERSION FOR INJECTION IN PRE-FILLED SYRINGE, 30 MICROGRAMS/DOSE

COMIRNATY, DISPERSION FOR INJECTION IN PRE-FILLED SYRINGE, 30 MICROGRAMS/DOSE

May 13, 2025

BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAMUSCULAR

Medical Information

J07BX03

Manufacturer Information

BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.

Pfizer Manufacturing Belgium NV

Active Ingredients

Bretovameran

30 μg/dose

bretovameran

Documents

Package Inserts

Comirnaty Dispersion for Injection in Prefilled Syringe 30mcg PI.pdf

Approved: May 13, 2025

Patient Information Leaflets

Comirnaty Dispersion for Injection in Prefilled Syringe 30mcg PIL.pdf

Approved: May 13, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COMIRNATY, DISPERSION FOR INJECTION IN PRE-FILLED SYRINGE, 30 MICROGRAMS/DOSE - HSA Approval | MedPath